Nachrichten zur Cannara Biotech Inc. Aktie

Cannara Biotech delivers record Fiscal 2025 revenue and profitability, achieving its first year of positive retained earnings and strong cash…

…

Cannara Biotech reported record Q1 2025 revenues of $25.1M, a 29% YoY increase, achieving 4.1% Canadian market share, 15th positive…

Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded…